April 29–30, 2025 | Brussels, Belgium
Pelago Bioscience is joining the 22nd BioPharma Drug Discovery Nexus Conference, a key meeting point for R&D leaders working to accelerate early-stage drug discovery through new tools, technologies, and strategies.
Visit us in Brussels to connect with our team and learn how CETSA® enables functional insights into target engagement—offering a powerful advantage in hit validation and lead optimization.
Representing Pelago Bioscience will be:
- Marianne Alksnis, Regional Sales Director
- Isabel Martin Caballero, Project Advisor
Isabel will also participate in the conference panel discussion:
Panel Title: The Evolving Landscape of Lead Discovery Tools
Panelist: Isabel Martin Caballero
Date: April 29–30 (exact time to be confirmed)
If you’re attending, we welcome you to stop by our booth to discuss how CETSA can help improve decision-making early in your pipeline.
Want to set up a meeting during the event?
Book a time with our team:
More event details: https://nexus-conference.com/ddneu/